Skip to content

New analysis shows benefits of offering two doses of COVID-19 vaccine to children aged 12-17 clearly outweigh risks (30 September 2021)

by Patient-Safety-Learning

· 1,200 views

Summary

A new analysis of the risks and benefits of offering two doses of COVID-19 vaccination to all 12-17 year olds in England shows that the benefits clearly outweigh the risks, given the current high case rates. In the UK currently a single dose of vaccine is recommended for all 12-17 year olds.

The research, which is in press with the Journal of the Royal Society of Medicine, estimates hospital and ICU admissions, deaths and cases of long COVID averted over a 16-week period by vaccinating all 12-17 year olds in England. The analysis includes high and low case rate scenarios.

New analysis shows benefits of offering two doses of COVID-19 vaccine to children aged 12-17 clearly… https://www.rsm.ac.uk/media-releases/2021/new-analysis-shows-benefits-of-offering-two-doses-of-covid…
    • 0

    User Feedback

    Recommended Comments

    There are no comments to display.

    Create an account or sign in to comment

    Registered address: Patient Safety Learning, China Works SB203, 100 Black Prince Road Vauxhall, London, SE1 7SJ

    Account

    Navigation

    Search

    Search

    Configure browser push notifications
    Chrome (Android)
    1. Tap the lock icon next to the address bar.
    2. Tap Permissions → Notifications.
    3. Adjust your preference.
    Chrome (Desktop)
    1. Click the padlock icon in the address bar.
    2. Select Site settings.
    3. Find Notifications and adjust your preference.